TFXのチャート
TFXの企業情報
symbol | TFX |
---|---|
会社名 | Teleflex Incorporated (TELEFLEX INC) |
分野(sector) | |
産業(industry) | |
業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連(Health Care) |
概要 | テレフレックス(Teleflex Incorporated)は医療技術製品のグローバルなプロバイダー。同社は主に、クリティカルケア及び手術での一般的な診断と治療方法向けに、人体へのアクセスを提供するために使用される使い捨て医療機器の開発・製造・供給を行う。同社は130カ国以上における病院・医療機関向けにサービスを提供する。同社の航空宇宙製品は、商業航空貨物向けの貨物取扱システム、コンテナ及びパレットを含む。同社の商品は、海洋産業向けのドライバーコントロール、エンジンアセンブリおよび駆動部品を含む。同社は救命救急、外科ケア、心臓ケア、並びに相手先商標製品製造業者(OEM)と開発サービスの4つのグループに分類される一連の医療技術製品を提供する。同社は医療、航空宇宙及び商業という3つの事業セグメントを運営する。平成24年5月、同社は二股の遠位端付きの「EZ-Blocker」の使い捨て可能なカテーテル製品ラインを取得した。平成24年7月、同社はHotspur Technologies Inc.を買収した。 テレフレックスは医療技術製品と関連サ―ビスを提供。バスキュラ―アクセス、麻酔・気道管理、呼吸管理、泌尿器などの治療に使用される製品、ライゲ―ションやクロ―ジャ―など低侵襲手術(ポ―トアクセス法)用の手術用具、体液管理製品、診断用カテ―テルおよび関連機器、整形外科用イントロデュ―サ―システム、特殊縫合器具、その他手術用器具を取り扱う。 Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applys purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Its portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. |
本社所在地 | 550 East Swedesford Road Suite 400 Wayne PA 19087 USA |
代表者氏名 | Liam J. Kelly |
代表者役職名 | President Chief Executive Officer |
電話番号 | +1 610-225-6800 |
設立年月日 | 15858 |
市場名 | NYSE(ニューヨーク証券取引所) |
ipoyear | 年 |
従業員数 | 15200人 |
url | www.teleflex.com |
nasdaq_url | |
adr_tso | |
EBITDA | (百万ドル) 609.52600 |
終値(lastsale) | |
時価総額(marketcap) | |
時価総額 | (百万ドル) 13926.44000 |
売上高 | (百万ドル) 2448.38300 |
企業価値(EV) | (百万ドル) 15728.10400 |
当期純利益 | (百万ドル) 196.43200 |
決算概要 | BRIEF: For the fiscal year ended 31 December 2018 Teleflex Incorporated revenues increased 14% to $2.45B. Net income before extraordinary items decreased 25% to $196.4M. Revenues reflect All Other segment increase of 66% to $389.3M EMEA segment increase of 9% to $603.8M Interventional North America segment increase of 19% to $261.6M United States segment increase of 16% to $1.45B Europe segment increase of 14% to $671.3M. |
TFXのテクニカル分析
TFXのニュース
CL King initiates coverage of Teleflex at ''buy'' with a price target of $293.00 2023/05/30 13:23:35 Investing.com
https://www.investing.com/news/pro/teleflex-inc-receives-investment-bank-analyst-rating-update-3093944
CL King Starts Teleflex at Buy 2023/05/30 13:21:01 Investing.com
https://www.investing.com/news/pro/cl-king-starts-teleflex-at-buy-432SI-3093943
The USA Knotless Surgical Sutures Market is Expected to Reach a Valuation of US$ 258.7 million by 2033, with a Steady Growth Rate of 3.6% CAGR: Future Market Insights, Inc. 2023/05/25 09:16:00 Accesswire
NEWARK, DE / ACCESSWIRE / May 25, 2023 / As per Future Market Insights'' latest industry analysis, the valuation for the USA knotless surgical sutures market was around US$ 175.7 Million in 2022 and is projected to exhibit a CAGR growth of close to 3.6% over the forecast period, with an estimated valuation of US$ 258.7 Million in 2033. Over the years, the USA market for knotless surgical sutures has seen tremendous growth. Key factors driving the market include technological advancements in terms of the usage of synthetic materials in creating surgical sutures, the development of absorbable sutures, increasing export opportunities, and rising disposable income. For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2033 - Download a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17299 Leading companies are inclined towards extensive research in order to develop new and improved versions of knotless surgical sutures. These include sutures with synthetic materials to provide exceptional tissue holding properties, sutures with properties like antibacterial or Triclosan-coated polyglactin 910 coated sutures, barbed sutures, sutures with braiding technologies, or absorbable sutures made of fibresthat line animal intestines or artificially created polymers.
Commonwealth Equity Services LLC Raises Stock Position in Teleflex Incorporated (NYSE:TFX) 2023/05/22 08:36:48 The AM Reporter
Commonwealth Equity Services LLC boosted its position in shares of Teleflex Incorporated (NYSE:TFX – Get Rating) by 1.3% in the fourth quarter, HoldingsChannel reports. The fund owned 4,646 shares of the medical technology company’s stock after purchasing an additional 61 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Teleflex were worth $1,160,000 as […]
Lung Cancer Surgery Market to Witness Huge Growth by 2029 | Accuray, Ethicon, Teleflex 2023/05/11 12:10:22 EIN News Healthcare
Stay up-to-date with Global Lung Cancer Surgery Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. PUNE, MAHARASHTRA, INDIA, May 11, 2023 /EINPresswire.com/ -- The Latest Released Lung …
Teleflex downgraded at Wolfe on valuation concerns 2023/04/26 14:50:17 Seeking Alpha
Teleflex Incorporated (TFX) fell in the morning hours Wednesday after Wolfe Research downgraded the medical device maker, citing valuation concerns. Read more here.
Teleflex to Present at the Bank of America Securities 2023 Health Care Conference 2023/04/25 10:30:00 GlobeNewswire
WAYNE, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2023 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 9, 2023, at 10:00 a.m. (PT).
Teleflex Announces First Quarter 2023 Earnings Conference Call Information 2023/04/20 10:30:00 GlobeNewswire
WAYNE, Pa., April 20, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 4, 2023.
Teleflex Incorporated (NYSE:TFX) Shares Sold by Hartford Investment Management Co. 2023/04/02 09:10:41 The AM Reporter
Hartford Investment Management Co. lowered its stake in shares of Teleflex Incorporated (NYSE:TFX – Get Rating) by 24.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,399 shares of the medical technology company’s stock after selling 1,073 shares during the quarter. Hartford Investment […]
Teleflex: Product Launches In Asia And FCF Could Imply Undervaluation (NYSE:TFX) 2023/03/30 15:07:38 Seeking Alpha
Teleflex Incorporated delivered beneficial guidance for the year 2023 and optimistic results in Q4. Click here to see why TFX stock is a Buy.
Teleflex Incorporated – Consensus Indicates Potential 11.1% Upside 2022/11/27 16:40:02 DirectorsTalk
Teleflex Incorporated found using ticker (TFX) have now 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 330 and 215 with the average target price sitting at 250.77. Now with the previous closing price of 225.71 this would imply there is a potential upside of 11.1%. The day 50 moving average is 207.33 and the 200 moving average now moves to 266.01. The market capitalisation for the company is $10,579m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $11,754m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Is it a Great Time to Exit Your Teleflex (TFX) Position? 2022/11/21 14:59:26 Insider Monkey
ClearBridge Investments, an investment management firm, published its “Mid Cap Growth Strategy” third-quarter 2022 investor letter – a copy of which can be downloaded here. The ClearBridge Mid Cap Growth Strategy underperformed the Russell Midcap Growth Index during the third quarter. On an absolute basis, the Strategy had losses across eight of the 10 sectors […]
Teleflex Earns Top Spot in MedReps Best Places to Work 2023 Ranking 2022/11/21 11:30:00 GlobeNewswire
WAYNE, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced it was named a MedReps.com 2023 Best Places to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year the company has been on the list.
Medical Corrugated Tubing Market to Witness Huge Growth by Key Players: Corma, Pennine, Romax Hose, Parker Hannifin, Teleflex, OmegaFlex 2022/11/18 12:03:51 OpenPR
According to Market Study Report, Medical Corrugated Tubing Market provides a comprehensive analysis of the Medical Corrugated Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in
Teleflex to Present at the 34th Annual Piper Sandler Healthcare Conference 2022/11/16 11:30:00 GlobeNewswire
WAYNE, Pa., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34 th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Wednesday, November 30, 2022 at 1:30 p.m. (ET).